Evidence shows that aluminum separates iron from its bound proteins, turning it into a toxin. Vaccines are a probable source of this excess aluminum. Dr. Blaylock explains.
by Russell L. Blaylock, MD, CCN
27 March 2011
Breast cancer is one of the leading causes of cancer death in women worldwide and breast cancer rates are increasing rapidly.
A compelling number of studies, though not all, have shown that free iron concentrations in breast tissue, especially the ductal tissue, is playing a major role in stimulating cancer development and eventual progression to aggressive, deadly cancers.1,2
Cancers are Very Dependent on Iron
A recent report from the Department of Biomolecular Sciences in Urbino Italy, found that fluid taken from the nipple of cancer patients contained significantly higher levels of aluminum than did nipple fluid taken from women without breast cancer—approximately twice as much aluminum.4
A number of studies have found that extracting nipple fluid by a breast pump (in both premenopausal and postmenopausal women) is a simple way to study the microenvironment of the ductal tissue, the site of development of most breast cancers.5
Examining this ductal fluid is an excellent way to measure such things as iron levels, ferritin (an iron-binding protein), CRP (a measure of breast inflammation) and aluminum.
This observation has been confirmed in other studies.
In previous studies researchers found that one’s intake of iron did not necessarily correlate with risk of breast cancer, but rather the release of iron from its protective proteins, such as ferritin and transferrin was critical.7